Mapping the Impact of Genomics in Blood Cancers: Yesterday, Today & Tomorrow Nalley, Catlin Nalley, Catlin Less Oncology Times. 41(S22):1-5, November 20, 2019. Favorites PDF Get Content & Permissions Free
Selinexor + Dexamethasone in Triple-Class Refractory Multiple Myeloma Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(S22):1,8-9, November 20, 2019. Favorites PDF Get Content & Permissions Free
Examining Facility & Provider Influence on Multiple Myeloma Survival Perron, Michelle Perron, Michelle Less Oncology Times. 41(S22):6,9, November 20, 2019. Favorites PDF Get Content & Permissions Free
Optimizing Care in Patients With Chronic Myelogenous Leukemia Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(S22):12, November 20, 2019. Favorites PDF Get Content & Permissions Free
Tisagenlecleucel Demonstrates Durable Efficacy in Relapsed/Refractory DLBCL May, Brandon May, Brandon Less Oncology Times. 41(S22):15, November 20, 2019. Favorites PDF Get Content & Permissions Free
Targeting MLL-Rearranged Leukemia: An Important Step Perron, Michelle Perron, Michelle Less Oncology Times. 41(S22):17, November 20, 2019. Favorites PDF Get Content & Permissions Free
Novel Therapies Now Standard of Care in Acute Myeloid Leukemia Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(S22):18, November 20, 2019. Favorites PDF Get Content & Permissions Free
Debate: Venetoclax Combinations New Standard of Care for AML Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(S22):19, November 20, 2019. Favorites PDF Get Content & Permissions Free
Combination Treatment in High-Risk Cytogenetic Multiple Myeloma Vidaurri, Vincent Vidaurri, Vincent Less Oncology Times. 41(S22):20, November 20, 2019. Favorites PDF Get Content & Permissions Free
Transplant-Eligible Newly Diagnosed Multiple Myeloma Vidaurri, Vincent Vidaurri, Vincent Less Oncology Times. 41(S22):21, November 20, 2019. Favorites PDF Get Content & Permissions Free
Subcutaneous Daratumumab With Standard Therapy in Multiple Myeloma Vidaurri, Vincent Vidaurri, Vincent Less Oncology Times. 41(S22):22, November 20, 2019. Favorites PDF Get Content & Permissions Free
Research Minute: Enhance Your Practice With the Latest Hematology/Oncology Research Less Oncology Times. 41(S22):23, November 20, 2019. Favorites PDF Get Content & Permissions Free
Discussing Treatment of CLL in the Era of Novel Therapeutic Agents Less Oncology Times. 41(S22):10-11, November 20, 2019. Favorites PDF Get Content & Permissions Free
Choosing Between Academic Research or Community Clinical Practice Lacorte, Sarah Lacorte, Sarah Less Oncology Times. 41(S22):16-17, November 20, 2019. Favorites PDF Get Content & Permissions Free
